Clinical Trial

IPP Placement & Intracavernosal Block

Study acronym: IPP
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The inflatable penile prosthesis (IPP) is the gold standard for surgical management of erectile dysfunction (ED) and there is no consensus on the best postoperative pain management regimen. In the wake of the opioid epidemic, postoperative pain management is heavily scrutinized. The National Institute of Health estimated over 81,000 individuals died following overdose of any opioids in 2022 alone; of these, over 14,000 deaths were linked to prescription opioids. Thus, strategies to minimize postoperative pain should not only improve patient experience but also lessen the need to escalate to opioid usage.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-07 -> 2027-09 2026-04-01
minor Completion pushed: 2027-08 -> 2027-10 2026-04-01
Trial Details
NCT Number NCT07246642
Lead Sponsor Wake Forest University Health Sciences
Conditions Erectile Dysfunction (ED)
Enrollment 100 participants
Start Date 2026-09
Primary Completion 2027-09 (estimated)
Study Completion 2027-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-26